Elevated vaginal inflammation may increase birth risks in pregnant women with IBD, though healthier diets may help mitigate ...

Pregnant individuals with inflammatory bowel disease (IBD) have higher levels of pro-inflammatory immune molecules, known as ...

SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced a business ...

Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced the expansion of its Scientific Advisory ...

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

Totus will review interim Phase 1 clinical data from its lead PI3Ka program, a covalent pan-mutant, a-specific inhibitor which is currently in clinical development for metastatic breast cancer and ...

IDOR-1117-2520 is now in a Phase 2 proof-of-concept trial in psoriasis, with the potential to expand into additional autoimmune conditions where the CCR6-CCL20 pathway plays a pathogenic role.

Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

In a joint study by researchers at the University of Rochester, US, and Indian researchers found that immune cells in the brain act differently in male and female mice with Alzheimer's disease.

When the first cells appeared on Earth approximately 3.8 billion years ago, viruses were already here to greet them. Ever since, viruses have been devising ways to infect cells, and cells have been ...

Please provide your email address to receive an email when new articles are posted on . Interferon lambda-encoding messenger RNA drug ETH47 was generally safe in healthy individuals. A phase 2a trial ...